Schedule of Reconciliation of the (Loss)/Earnings and Shares used in Calculating Basic and Diluted EPS |
The following table presents a reconciliation of the earnings/(loss) and shares used in calculating basic and diluted earnings/(loss) per share for the three and six months ended June 30, 2025 and 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | (In Thousands, Except Per Share Amounts) | | 2025 | | 2024 | | 2025 | | 2024 | Basic Earnings/(Loss) per Share: | | | | | | | | | Net income/(loss) to common stockholders | | $ | 33,184 | | | $ | 41,946 | | | $ | 74,360 | | | $ | 65,159 | | Dividends declared on preferred stock | | (10,560) | | | (8,218) | | | (18,779) | | | (16,437) | | Dividends, dividend equivalents and undistributed earnings allocated to participating securities | | (200) | | | (114) | | | (406) | | | (281) | | Net income/(loss) attributable to common stockholders - basic | | $ | 22,424 | | | $ | 33,614 | | | $ | 55,175 | | | $ | 48,441 | | Basic weighted average common shares outstanding | | 103,705 | | | 103,446 | | | 103,740 | | | 103,310 | | Basic Earnings/(Loss) per Share | | $ | 0.22 | | | $ | 0.32 | | | $ | 0.53 | | | $ | 0.47 | | | | | | | | | | | Diluted Earnings/(Loss) per Share: | | | | | | | | | Net income/(loss) to common stockholders - basic | | $ | 22,424 | | | $ | 33,614 | | | $ | 55,175 | | | $ | 48,441 | | Dividends, dividend equivalents and undistributed earnings allocated to participating securities | | — | | | — | | | — | | | — | | Interest expense on Convertible Senior Notes | | — | | | — | | | — | | | — | | Net income/(loss) attributable to common stockholders - diluted | | $ | 22,424 | | | $ | 33,614 | | | $ | 55,175 | | | $ | 48,441 | | Basic weighted average common shares outstanding | | 103,705 | | | 103,446 | | | 103,740 | | | 103,310 | | Unvested and vested restricted stock units | | 1,602 | | | 1,730 | | | 1,536 | | | 1,643 | | Effect of assumed conversion of Convertible Senior Notes to common shares | | — | | | — | | | — | | | — | | Diluted weighted average common shares outstanding (1) | | 105,307 | | | 105,176 | | | 105,276 | | | 104,953 | | Diluted Earnings/(Loss) per Share | | $ | 0.21 | | | $ | 0.32 | | | $ | 0.52 | | | $ | 0.46 | |
(1)At June 30, 2025 and 2024, the Company had approximately 931,000 and 341,000 equity instruments outstanding that were excluded from the calculation of diluted EPS for the three and six months ended June 30, 2025 and 2024, as they were determined to be anti-dilutive. These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $10.45 and $11.20, respectively. These equity instruments may have a dilutive impact on future EPS.
|